Please login to the form below

Not currently logged in
Email:
Password:

Cadence Pharma

This page shows the latest Cadence Pharma news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma. The Irish group will acquire Amitizia, Rescula and a pipeline of rare disease projects. ... bought Cadence Pharma for $1.3bn, Questcor for $6.5bn, immunotherapy outfit Therakos for $1.3bn and nuclear imaging

Latest news

  • Ireland's Mallinckrodt buys US regenerative medicine firm Ireland's Mallinckrodt buys US regenerative medicine firm

    Ireland's Mallinckrodt Pharma has continued its acquisitive streak with a deal to buy Stratatech, a US firm developing a biologic treatment for severe burns. ... Cadence Pharma and its injectable painkiller Ofirmev (acetaminophen).

  • Mallinckrodt cuts $5.6bn deal to buy Questcor Mallinckrodt cuts $5.6bn deal to buy Questcor

    Mallinckrodt cuts $5.6bn deal to buy Questcor. Irish company continues move from medical imaging to pharma products. ... It is the second transaction for Mallinckrodt in as many months, having announced a $1.3bn bid for Cadence Pharma and its

  • Mallinckrodt offers $1.3bn for Cadence Pharma

    Mallinckrodt offers $1.3bn for Cadence Pharma. Deal would include injectable painkiller Ofirmev. ... Irish pharma company Mallinckrodt has agreed a $1.3bn deal to buy US biotech Cadence Pharmaceuticals and its fast-growing injectable painkiller Ofirmev.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics